These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30426509)

  • 1. Serum copper and zinc levels at diagnosis and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort.
    Fang AP; Chen PY; Wang XY; Liu ZY; Zhang DM; Luo Y; Liao GC; Long JA; Zhong RH; Zhou ZG; Xu YJ; Xu XJ; Ling WH; Chen MS; Zhang YJ; Zhu HL
    Int J Cancer; 2019 Jun; 144(11):2823-2832. PubMed ID: 30426509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum folate concentrations at diagnosis are associated with hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort study.
    Fang AP; Liu ZY; Liao GC; Chen PY; Wang XY; Zhang DM; Luo Y; Long JA; Zhong RH; Zhou ZG; Xu YJ; Xu XJ; Ling WH; Chen MS; Zhang YJ; Zhu HL
    Br J Nutr; 2019 Jun; 121(12):1376-1388. PubMed ID: 30935429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Bioavailable, Rather Than Total, 25-hydroxyvitamin D Levels Are Associated With Hepatocellular Carcinoma Survival.
    Fang AP; Long JA; Zhang YJ; Liu ZY; Li QJ; Zhang DM; Luo Y; Zhong RH; Zhou ZG; Xu YJ; Xu XJ; Ling WH; Chen MS; Zhu HL
    Hepatology; 2020 Jul; 72(1):169-182. PubMed ID: 31677282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum S-adenosylhomocysteine, rather than homocysteine, is associated with hepatocellular carcinoma survival: a prospective cohort study.
    Wusiman M; Huang SY; Liu ZY; He TT; Fang AP; Li MC; Yang MT; Wang C; Zhang YJ; Zhu HL
    Am J Clin Nutr; 2024 Sep; 120(3):481-490. PubMed ID: 39025328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma.
    Tamai Y; Iwasa M; Eguchi A; Shigefuku R; Sugimoto K; Hasegawa H; Takei Y
    PLoS One; 2020; 15(8):e0237370. PubMed ID: 32857769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum fibroblast growth factor 21 is associated with inferior hepatocellular carcinoma survival: A prospective cohort study.
    Liu ZY; Luo Y; Fang AP; Wusiman M; He TT; Liu XZ; Yishake D; Chen S; Lu XT; Zhang YJ; Zhu HL
    Liver Int; 2022 Mar; 42(3):663-673. PubMed ID: 34812573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Level of Plasma DNA Methylation is Associated with Overall Survival in Patients with Hepatocellular Carcinoma.
    Yeh CC; Goyal A; Shen J; Wu HC; Strauss JA; Wang Q; Gurvich I; Safyan RA; Manji GA; Gamble MV; Siegel AB; Santella RM
    Ann Surg Oncol; 2017 Nov; 24(12):3788-3795. PubMed ID: 28593503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediagnostic dietary intakes of vitamin A and β-carotene are associated with hepatocellular-carcinoma survival.
    Zhang DM; Luo Y; Yishake D; Liu ZY; He TT; Luo Y; Zhang YJ; Fang AP; Zhu HL
    Food Funct; 2020 Jan; 11(1):759-767. PubMed ID: 31915755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary intake and serum levels of copper and zinc and risk of hepatocellular carcinoma: A matched case-control study.
    Liu X; Zhang Y; Yishake D; Luo Y; Liu Z; Chen Y; Zhu H; Fang A
    Chin Med J (Engl); 2024 Mar; 137(5):596-603. PubMed ID: 38030414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum choline is associated with hepatocellular carcinoma survival: a prospective cohort study.
    Liu ZY; Yishake D; Fang AP; Zhang DM; Liao GC; Tan XY; Zhang YJ; Zhu HL
    Nutr Metab (Lond); 2020; 17():25. PubMed ID: 32256673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma.
    Köberle V; Kronenberger B; Pleli T; Trojan J; Imelmann E; Peveling-Oberhag J; Welker MW; Elhendawy M; Zeuzem S; Piiper A; Waidmann O
    Eur J Cancer; 2013 Nov; 49(16):3442-9. PubMed ID: 23810247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL4-induced liver cirrhosis and hepatocellular carcinoma in rats: relationship to plasma zinc, copper and estradiol levels.
    Frezza EE; Gerunda GE; Farinati F; DeMaria N; Galligioni A; Plebani F; Giacomin A; Van Thiel DH
    Hepatogastroenterology; 1994 Aug; 41(4):367-9. PubMed ID: 7959573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT).
    Murray LJ; Sykes J; Brierley J; Kim JJ; Wong RKS; Ringash J; Craig T; Velec M; Lindsay P; Knox JJ; Dawson LA
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):900-909. PubMed ID: 29976502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma.
    OuYang HY; Xu J; Luo J; Zou RH; Chen K; Le Y; Zhang YF; Wei W; Guo RP; Shi M
    Hepatology; 2016 Apr; 63(4):1227-39. PubMed ID: 26660154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum vitamin B(12) levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma.
    Lin CY; Kuo CS; Lu CL; Wu MY; Huang RF
    Nutr Cancer; 2010; 62(2):190-7. PubMed ID: 20099193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans.
    Stepien M; Hughes DJ; Hybsier S; Bamia C; Tjønneland A; Overvad K; Affret A; His M; Boutron-Ruault MC; Katzke V; Kühn T; Aleksandrova K; Trichopoulou A; Lagiou P; Orfanos P; Palli D; Sieri S; Tumino R; Ricceri F; Panico S; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Lasheras C; Bonet Bonet C; Molina-Portillo E; Dorronsoro M; Huerta JM; Barricarte A; Ohlsson B; Sjöberg K; Werner M; Shungin D; Wareham N; Khaw KT; Travis RC; Freisling H; Cross AJ; Schomburg L; Jenab M
    Br J Cancer; 2017 Feb; 116(5):688-696. PubMed ID: 28152549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.
    Huang GQ; Zhu GQ; Liu YL; Wang LR; Braddock M; Zheng MH; Zhou MT
    Oncotarget; 2016 Feb; 7(5):5429-39. PubMed ID: 26716411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-diagnostic copper and zinc biomarkers and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort.
    Stepien M; Jenab M; Freisling H; Becker NP; Czuban M; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Mancini FR; Savoye I; Katzke V; Kühn T; Boeing H; Iqbal K; Trichopoulou A; Bamia C; Orfanos P; Palli D; Sieri S; Tumino R; Naccarati A; Panico S; Bueno-de-Mesquita HBA; Peeters PH; Weiderpass E; Merino S; Jakszyn P; Sanchez MJ; Dorronsoro M; Huerta JM; Barricarte A; Boden S; van Guelpen B; Wareham N; Khaw KT; Bradbury KE; Cross AJ; Schomburg L; Hughes DJ
    Carcinogenesis; 2017 Jul; 38(7):699-707. PubMed ID: 28575311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.